Evidence map›Paper›PMID 31576288›Full record

ArticleAnnals of translational medicine2019

A novel macrophage subtype directs hematopoietic stem cell homing and retention.

Marcin Wysoczynski, Joseph B Moore, Shizuka Uchida

Abstract readEditorialComment
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Hematopoietic Stem Cells and Their Niche in Bone Marrow.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Marcin WysoczynskiInstitute of Molecular Cardiology, Department of Medicine, University of Louisville, Louisville, KY, USA.
Joseph B MooreInstitute of Molecular Cardiology, Department of Medicine, University of Louisville, Louisville, KY, USA.
Shizuka UchidaInstitute of Molecular Cardiology, Department of Medicine, University of Louisville, Louisville, KY, USA.

Funding

Tumor Necrosis Factor Modulation of CPCsP01HL078825 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BOLLI, ROBERTO · 2005 to 2021
$37.6M
TBDP30GM127607 · NIGMS · UNIVERSITY OF LOUISVILLE · PI HILL, BRADFORD GUY · 2018 to 2022
$6.3M
The Role of Cardiomyogenic Lineage Commitment in Cardiac Mesenchymal Cell-Mediated Extracellular Vesicle Signaling and Cardiac RepairR01HL141081 · NHLBI · UNIVERSITY OF LOUISVILLE · PI MOORE IV, JOSEPH B · 2018 to 2022
$1.9M
The role of bioactive lipids in CMC-induced myocardial repair.R01HL141191 · NHLBI · UNIVERSITY OF LOUISVILLE · PI WYSOCZYNSKI, MARCIN · 2019 to 2023
$1.9M
NHLBI NIH HHS P01 HL078825NHLBI NIH HHS R01 HL141081NHLBI NIH HHS R01 HL141191NIGMS NIH HHS P30 GM127607
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31576288
PMCPMC6685852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.